PhD defence by Pelle Lau Ishøy: GLP-1 Receptor Agonist Treatment in Schizophrenia Patients with Obesity

Tidspunkt Ikon
Dato: 03-05-2017
Tid: 15:00
$Resources:Resource,alt_meeting_place;

​Auditorium C, Entrance 7, Rigshospitalet - Glostrup, Nordre Ringvej 29-67, 2600 Glostrup

Tilmelding
Ingen tilmelding
After the defence, CINS and Psychiatric Center Glostrup will be hosting a reception
in the conference room of the Research Unit, Psychiatric Center Glostrup.

Assessment Committee

  • Merete Nordentoft, MD, DMSc, Professor (Chair Person)
    Research Unit, Mental Health Centre Copenhagen, Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Margaret Hahn, MD, PhD, Assistant Professor of Psychiatry Centre for Addiction and Mental Health Institute of Medical Science, University of Toronto, Canada
  • Wiepke Cahn, MD, PhD, Professor and Head of Department Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, The Netherlands

Supervisors

  • Birte Y Glenthøj, MD, DMSc, Professor and Chair of Research (Faculty Supervisor) Center for Neuropsychiatric Schizophrenia Research (CNSR) and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark
  • Bjørn H Ebdrup, MD, PhD, Senior Scientist Center for Neuropsychiatric Schizophrenia Research (CNSR) and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark
  • Filip Krag Knop, MD, PhD, Professor, Director of Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark


Redaktør